Last reviewed · How we verify
NCT06645743
Retrospective Analysis of Clinical and CT Features to Predict Spread Through Air Space in Stage IA Lung Adenocarcinoma
trial in Tomography, X-Ray Computed in 1,100 participants. Not yet recruiting.
21 February 2025
Quick facts
| Lead sponsor | The Third Affiliated Hospital of Kunming Medical College. |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 1,100 |
| Start date | 25 October 2024 |
| Primary completion | 21 February 2025 |
| Estimated completion | 21 February 2025 |
| Sites | 1 location across China |
Conditions studied
- Tomography, X-Ray Computed — all drugs for Tomography, X-Ray Computed →
- Spread Through Air Space — all drugs for Spread Through Air Space →
- Clinical Features — all drugs for Clinical Features →
- Stage IA Adenocarcinoma of Lung — all drugs for Stage IA Adenocarcinoma of Lung →
Sponsor
The Third Affiliated Hospital of Kunming Medical College.
Who can join
18 and older, any sex, with Tomography, X-Ray Computed or Spread Through Air Space. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to provide a basis for the selection of surgical methods for patients with stage IA lung adenocarcinoma. Air cavity dissemination is a poor prognostic factor for patients with stage IA lung adenocarcinoma. We retrospectively collected clinical and imaging data of stage IA lung adenocarcinoma patients. Independent risk factors associated with spread through air space in stage IA lung adenocarcinoma patients were analyzed, so as to predict the occurrence of spread through air space and provide basis for the selection of surgical methods
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06645743
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tomography, X-Ray Computed
Currently open trials in the same condition.
- NCT07016477 — Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha PCD-CT Before TAVI Procedure · recruiting
Other The Third Affiliated Hospital of Kunming Medical College. trials
Trials by the same sponsor.
- NCT06685458 — Constructing a Predictive Model for Differentiating Between Benign and Malignant Solid Pulmonary Nodules Based on Clinic · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06645743 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Third Affiliated Hospital of Kunming Medical College.
- Last refreshed: 17 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06645743.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing